DR. ANTHONY J. BERNI, M.D.

Plain English
This study looked at the use of a medication called pegcetacoplan to treat geographic atrophy in people with age-related macular degeneration. Researchers followed 97 patients for one year and found that pegcetacoplan reduced the growth rate of geographic atrophy by 37%, from 0.33 mm/year before treatment to 0.21 mm/year after treatment. Although patients experienced a slight decline in vision during this time, the treatment showed promise in slowing disease progression. Who this helps: This research benefits patients with geographic atrophy from age-related macular degeneration.

Plain English
This research looked at various non-infectious eye inflammation disorders, specifically those affecting the outer retina, that are difficult to diagnose and treat. It found that many cases of these disorders don't fit standard descriptions, making it challenging for doctors to identify and properly manage them. The study highlighted the need for improved diagnostic methods and better understanding of these conditions to ensure patients receive appropriate care. Who this helps: This helps patients experiencing eye disorders and their doctors in making accurate diagnoses and treatment plans.

Plain English
This study looked at two types of retinitis pigmentosa (RP) – one that occurs alone (non-syndromic) and one that is part of a syndrome (syndromic) – to see how they differ using advanced imaging techniques. Out of 18 patients, most (72.2%) had Usher syndrome type 2 and were younger but had worse vision than those with non-syndromic RP. Although there were some differences in eye structure and vascular health between the two groups, they were not significant enough to draw strong conclusions, indicating that both groups may experience similar changes in their eyes despite their differences. Who this helps: This research benefits both patients with retinitis pigmentosa and the doctors who treat them.

Plain English
This paper examined a medical procedure called left atrial appendage occlusion (LAAO), which helps prevent strokes in patients with a heart condition called atrial fibrillation who can't take blood thinners. The findings indicate that while LAAO is already considered safe, there's a need for more detailed data on its effectiveness and guidelines for how to perform it better. Improving this procedure could make it a standard treatment option for many patients at risk of stroke. Who this helps: This helps patients with atrial fibrillation who cannot use anticoagulant medications.

Plain English
This research reviews a specific type of eye condition called non-exudative choroidal and macular neovascularizations (NV), which are related to various retinal diseases. The study highlights that new, non-invasive imaging techniques like optical coherence tomography make it easier to detect and monitor these conditions. It emphasizes the need for careful management and treatment due to the differences in how these lesions develop and affect patients. Who this helps: This helps patients with retinal disorders and their doctors.

Plain English
This study looked at patients with a specific eye condition called Type 3 macular neovascularization (MNV) to measure different types of fluid in their retinas and see how this affects their vision before and after treatment. Researchers found that patients had an average vision score of 0.51 before treatment, which improved to 0.33 after receiving a specific therapy, anti-VEGF. Notably, the amount of fluid in the inner retina was linked to better vision outcomes, meaning that less fluid can lead to better sight after treatment. Who this helps: This helps patients with age-related macular degeneration and their eye care doctors.

Plain English
This study looked at two different types of eye scans—spectral-domain OCT angiography (SD-OCTA) and swept-source OCT angiography (SS-OCTA)—to see if they give similar measurements of harmful spots called hyperreflective foci (HRF) in patients with intermediate age-related macular degeneration (iAMD). The researchers examined 40 eyes from 35 patients and found that the measurements from both types of scans were nearly identical, with a correlation coefficient of 0.94, meaning they agree very well. This is important because it shows that either scan can be reliably used to assess the damage caused by iAMD, which can guide treatment decisions. Who this helps: This helps patients with age-related macular degeneration and their doctors in monitoring disease progression.

Plain English
This study looked at how common macular atrophy is in patients with neovascular age-related macular degeneration (AMD) who are being treated with anti-VEGF therapy. The researchers found that about 29% of patients developed new macular atrophy within 24 months of treatment. This matters because it highlights a significant potential side effect of the therapy, which can lead to vision loss. Who this helps: This helps patients with neovascular AMD and their doctors in understanding the risks of treatment.

Plain English
This study looked at how carotid endarterectomy (CEA), a surgery to clear blocked arteries in the neck, affects blood flow in the eyes over time. Researchers examined 58 eyes from 29 patients and found that just after the surgery, there was a significant increase in blood flow to the eye (with a p-value of less than 0.001), and this improvement in choroidal thickness lasted even after 30 days (p-value of 0.02). However, other measures of blood flow didn’t show significant changes, meaning while there were some positive effects on eye health from the surgery, not all the expected improvements occurred. Who this helps: This research is helpful for patients with carotid artery disease and their doctors, as it highlights potential benefits of surgery for eye health.

Plain English
This study looked at how a 12-week virtual workout program based on the Army Combat Fitness Test (ACFT) affects women’s fitness. Nine women, aged around 20, completed the program and showed an average improvement of about 7% in their overall ACFT scores, going from 487 to 522 points. This improvement is important because it indicates that a structured workout program can help women prepare better for military fitness standards. Who this helps: This research benefits female soldiers and military trainers.

Plain English
This study looked at changes in the eye's choroid layer as people advanced from a type of age-related macular degeneration (AMD) called intermediate AMD to a more severe form known as neovascular AMD. Researchers found that the overall choroidal volume increased from 0.156 mm³ to 0.163 mm³ when neovascular AMD appeared, reflecting a significant change. After one year of treatment with anti-VEGF therapy, the choroidal volume returned to nearly its original level. Who this helps: Patients with AMD and their doctors can benefit from understanding these changes and treatment effects.

Plain English
This study looked at how certain changes in the eyes of people with intermediate age-related macular degeneration (iAMD) can predict the worsening of their condition. Researchers found that, among 171 eyes studied, 48% developed large areas of abnormal light transmission called hypertransmission defects over about five years. Specifically, they discovered that the size of certain areas of thickening in the retinal pigment epithelium (rpeHRF) was a strong indicator of disease progression, more so than other factors like drusen volume. Who this helps: This research helps doctors better predict the progression of age-related macular degeneration in their patients.

Plain English
This study looked at whether injecting a special type of blood treatment, made from umbilical cord blood, into the eyes of older adults with late-stage dry age-related macular degeneration (AMD) could help slow down the disease. The results showed that the growth of damaged areas in the treated eyes was 14.5% slower compared to the untreated eyes, although neither group experienced a significant change in vision over the follow-up period. These findings suggest that this treatment might be a safe option for slowing AMD progression, but more research is needed. Who this helps: This helps patients with late-stage dry age-related macular degeneration.

Plain English
This study looked at what factors might lead to patients needing a permanent pacemaker within 30 days after getting a specific heart valve replacement called the Navitor. Out of 173 patients, 54 (about 31%) ended up needing the pacemaker. Key findings showed that men, people with chronic obstructive pulmonary disease (COPD), those who had a specific heart condition called right bundle branch block, and those who had a larger valve size or deeper implantation were more likely to need a pacemaker. Who this helps: This research benefits patients undergoing transcatheter aortic valve implantation, especially those with specific pre-existing conditions.

Plain English
This study looks at dangerous coronary plaques, called vulnerable plaques, that can lead to heart attacks. Researchers found that these plaques are present in about two-thirds of heart attack cases and can be identified using advanced imaging techniques. New treatment options, including medications and minimally invasive procedures like stents, aim to prevent heart issues by addressing these plaques before they cause serious problems. Who this helps: This helps patients at risk of heart disease and doctors who treat them.

Plain English
This study focused on improving how doctors measure blood flow problems in a part of the eye (the choriocapillaris) in patients with age-related macular degeneration (AMD) using a special imaging technique. The researchers identified a new method to adjust for signal loss caused by drusen, a common eye condition in AMD, which may lead to more accurate assessments. They found that carefully selecting an adjustment level allows for better detection of true blood flow deficits, which is important for understanding how AMD progresses and affects vision. Who this helps: This helps doctors and researchers working with patients affected by age-related macular degeneration.

Plain English
This study looked at how researchers use a specific imaging method called optical coherence tomography angiography (OCTA) to examine a part of the eye called the choriocapillaris in patients with age-related macular degeneration (AMD), which is a major cause of vision loss. The review found that out of 102 studies reviewed, there was a lot of variation in how the measurements were taken, which makes it hard to compare results and apply them to patient care. This matters because having standardized methods can improve how AMD is managed and help doctors make better decisions. Who this helps: This helps patients with age-related macular degeneration and their healthcare providers.

Plain English
This study looked at a specific type of eye condition called intermediate age-related macular degeneration (iAMD) to see how calcified drusen (CaD) affect the development of certain large defects in the eye. Researchers followed 171 eyes for nearly five years and found that eyes with larger areas of CaD were more likely to develop large choroidal hypertransmission defects. Specifically, those that developed these defects had an average CaD area of 0.037 mm² compared to 0.008 mm² in those that didn't, significantly increasing the risk of developing these defects. Who this helps: This research benefits patients with intermediate AMD by helping doctors better predict their risk of disease progression.

Plain English
This study looked at the effects of the drug Efgartigimod (EFG) in patients with myasthenia gravis, an autoimmune disease where the immune system mistakenly attacks the body's own nerve-muscle connections. Researchers found that after treatment with EFG, patients had increased levels of certain immune cells, including memory B cells and plasma cells, which correlated with improvements in their symptoms—specifically, almost a 50% better score on the Myasthenia Gravis evaluation. This matters because it reveals that EFG may not only reduce harmful antibodies but also promote beneficial immune responses that can help patients feel better. Who this helps: Patients with myasthenia gravis.

Plain English
This study looked at early-stage lung cancer patients who had surgery to remove their tumors, specifically focusing on why some patients experience cancer returning in distant parts of the body. The researchers found that about 11% of patients (28 out of 259) had distant relapses, and certain features of the tumors, like a more aggressive form (called G3) and the presence of tumor spread through air spaces, increased the risk of recurrence. These findings are important because they suggest that doctors might need to consider these tumor characteristics when assessing a patient’s chance of cancer returning after surgery. Who this helps: This helps doctors and oncologists in better predicting cancer recurrence in their patients.

Plain English
This study looked at how blood flow deficits in a part of the eye called the choriocapillaris relate to the development of larger defects in the retina in patients with intermediate age-related macular degeneration (iAMD). Researchers found that there were no significant blood flow issues before the large defects formed, but some issues did appear after the defects developed. This is important because it indicates that the loss of blood flow happens after the defects appear, which could help in understanding the progression of the disease and guiding future treatments. Who this helps: This helps patients with age-related macular degeneration and their doctors.

Plain English
This study focused on transcatheter aortic valve implantation (TAVI), which is a procedure used to treat narrowed heart valves, particularly in older patients. The research found that TAVI is becoming a common treatment for a wider range of patients, including younger and healthier ones, but it also highlighted the need for careful planning to ensure long-term success, like considering how long the valve will last and the risk of complications. This is important because as more patients receive TAVI, it’s crucial to ensure they have positive outcomes over their lifetime. Who this helps: This helps patients, especially older adults and those with heart valve issues.

Plain English
This study looked at how well a specific imaging technique (en face swept-source OCT) can measure damage in the center of the eye (macular atrophy) in patients with a severe eye condition called neovascular age-related macular degeneration (AMD). The researchers found that the average size of macular atrophy was 5.96 mm² using the OCT method and 7.10 mm² with another method (green autofluorescence), showing a meaningful difference but a strong agreement between the two (p < 0.001). This matters because it helps doctors understand how reliable these imaging techniques are when assessing eye damage, which is crucial for treating patients effectively. Who this helps: Patients with neovascular AMD and their doctors.

Plain English
In this study, researchers compared the effects of a new HIV treatment (cabotegravir plus rilpivirine given every two months) to a standard treatment (bictegravir/emtricitabine/tenofovir alafenamide) on weight and other metabolic changes in 687 participants over one year. They found that those on the new treatment lost a small amount of weight (about 0.4 kg), while those on the standard treatment gained a tiny bit (about 0.05 kg), and there were no significant changes in body composition or metabolic health in either group. This is important because it shows that the new treatment does not lead to significant weight gain or metabolic issues, making it a viable option for people with HIV. Who this helps: This helps patients living with HIV who are considering switching their treatment.

Plain English
This study looked at the presence of unusual structures called PHOMS in the eyes of patients with acute Leber's hereditary optic neuropathy (LHON), a condition that causes sudden vision loss. Researchers found PHOMS in 57.1% of the eyes examined, with most cases located in the outer part of the eye near the optic nerve. This finding is important because it helps doctors better understand the eye changes that happen with LHON and may lead to improved methods for diagnosing and monitoring this condition. Who this helps: This helps patients with LHON and their doctors.

Plain English
This research paper looks at a rare eye condition called pigmented paravenous chorioretinal atrophy (PPCRA), which causes pigment clumps to form around retinal veins. Most people with PPCRA don’t have any symptoms and generally keep normal vision unless the area central to their sight is affected. Advances in imaging technology, especially ultra-widefield imaging, have improved how doctors diagnose this condition, which may have a genetic component. Who this helps: This helps eye doctors in diagnosing and managing patients with PPCRA.

Plain English
This study looked at whether antidepressants, specifically SSRIs, could help patients with COVID-19 pneumonia recover better by reducing inflammation. Researchers analyzed the medical records of 1,236 patients and found that those who took SSRIs had lower levels of a specific inflammatory marker (IL-6) and a better recovery rate, with 77% recovering compared to 22.9% who died. This matters because it suggests that treating COVID-19 pneumonia with SSRIs may improve patient outcomes by reducing inflammation. Who this helps: This helps patients with COVID-19 pneumonia and their doctors.

Plain English
This study examined how the thickness of certain layers in the retina, called ganglion cell and inner plexiform layers (GC-IPL), can help predict vision outcomes in patients with dominant optic atrophy (DOA). Researchers found that the average visual acuity score for the 33 patients was 0.43, and the average GC-IPL thickness was 43.65 micrometers. The thickness of these layers was closely linked to the patients' vision, making it a useful indicator for assessing the progression of DOA. Who this helps: This helps patients with dominant optic atrophy by providing insights into their vision prognosis.

Plain English
This study looked at 45 eyes from individuals with a specific type of eye condition called extrafoveal geographic atrophy associated with age-related macular degeneration (AMD) to understand what factors might lead to further damage in the fovea, the part of the eye responsible for sharp central vision, over two years. They found that after 24 months, over half (57.8%) of the eyes had developed significant damage to their foveal area. Key predictors for this progression included the thickness of certain layers in the eye and specific signs visible through imaging, which helps to identify who might be at higher risk of vision loss in the future. Who this helps: This helps patients with AMD and eye doctors by providing insights into predicting vision loss.

Plain English
This study reviewed imaging techniques that help identify vitreoretinal lymphoma (VRL), a rare eye cancer. It found that various imaging methods, like color fundus photography and optical coherence tomography, can reveal signs of VRL, such as abnormal patterns in the retina and vitreous fluid. These tools help detect VRL earlier, which is crucial since timely diagnosis can lead to better treatment outcomes. Who this helps: This helps patients with suspected eye cancers and their doctors.

Plain English
This study looked at how macular atrophy (MA), a serious eye condition, develops in patients with a specific type of age-related macular degeneration (AMD) treated with anti-VEGF therapy. Among 41 participants, 92.7% (38 eyes) showed signs of macular atrophy after one year. The researchers found that MA can stem from different causes: some related to the growth of abnormal blood vessels, while others are linked to unrelated conditions like drusen. Who this helps: This information benefits patients with AMD and their doctors by providing insights into the progression of the disease and treatment outcomes.

Plain English
This study looked at how the structure of the eye affects vision in patients with multiple evanescent white dot syndrome (MEWDS). Researchers tracked 14 eyes from 13 patients over about 50 days, finding that initially, photoreceptors (light-sensitive cells in the eye) were damaged but then started to recover, with visual function improving over time at a rate of about 0.07 decibels per day. Specifically, they noted that eyes with greater initial vision loss improved faster and had a clear relationship between photoreceptor health and visual sensitivity. Who this helps: This research helps patients with MEWDS and their doctors by providing insight into how vision may recover over time.

Plain English
This study looked at using a new type of eye scan called Swept-Source OCT Angiography (SS-OCTA) to diagnose and monitor age-related macular degeneration (AMD) more effectively. The researchers found that a single SS-OCTA scan could provide detailed information about changes in the eye related to both forms of AMD—nonexudative and exudative—making it easier to track disease progression and treatment responses. This is important because it simplifies the process for patients and doctors, improving the management of AMD with just one kind of scan instead of several different tests. Who this helps: Patients with age-related macular degeneration and their doctors.

Plain English
This study focused on identifying special markers that indicate the development and worsening of geographic atrophy (GA), a severe form of age-related macular degeneration (AMD) that can lead to vision loss. Researchers reviewed various articles and found that certain features in eye scans, like the size and type of drusen (tiny deposits in the eye) and changes in retinal structure, can predict how GA develops and progresses. Understanding these markers is important because they can help doctors diagnose GA earlier and monitor it more effectively, especially as new treatments are being developed. Who this helps: Patients with age-related macular degeneration.

Plain English
This study looked at how certain types of eye deposits, called calcified drusen, affect the ability to see blood flow in the eyes of people with age-related macular degeneration. Researchers compared the blood flow under normal eyes, eyes with soft drusen, and eyes with calcified drusen. They found that while blood flow under calcified drusen seemed to be detected, it was actually just an illusion caused by light scattering, meaning real blood flow could not be measured accurately when these deposits were present. Who this helps: This information helps doctors better understand how to assess blood flow in patients with age-related macular degeneration.

Plain English
This study examined how certain markers in the eyes, specifically hyperreflective foci (HRF), relate to the progression of intermediate Age-related Macular Degeneration (iAMD) to more advanced stages. They found that nearly half (48%) of the 171 eyes studied developed persistent choroidal hypertransmission defects (hyperTDs) during follow-up, and that a larger HRF area is a strong predictor of this progression. This matters because identifying patients at higher risk for worsening vision can guide treatment decisions and clinical trial participation. Who this helps: This helps patients with early-stage Age-related Macular Degeneration.

Plain English
This study looked at whether lung ultrasound (LUS) could be used instead of chest X-rays (CXR) to check on patients after major lung surgeries. They found that LUS had an 84% agreement rate with CXR right after surgery and an even higher 89% agreement after chest drains were removed. This matters because using LUS can help avoid unnecessary radiation exposure from X-rays, particularly for checking for conditions like pneumothorax and fluid buildup in the lungs. Who this helps: This helps patients undergoing thoracic surgery by reducing their exposure to radiation.

Plain English
This study looks at non-coding RNAs, which are tiny molecules in our cells that don't code for proteins, to understand their role in myasthenia gravis (MG), an autoimmune disease that causes muscle weakness. The researchers found that certain microRNAs in the thymus and blood of MG patients are changed compared to healthy individuals, suggesting these molecules might help regulate the immune system and could be used as markers to tailor treatments for patients. This research is important because it may lead to better care and more personalized treatment options for people with MG. Who this helps: Patients with myasthenia gravis.

Plain English
This study looked at the long-lasting effects of large bright spots, called choroidal hypertransmission defects (hyperTDs), in patients with age-related macular degeneration (AMD). Researchers followed 202 eyes with these defects for nearly 47 months and found that an overwhelming 99.6% (1,718) of the hyperTDs stayed the same, indicating they are a sign that the disease is worsening. This information is important because it helps identify when AMD is progressing, which can guide treatment options for patients and serve as a measure in clinical trials aimed at slowing disease progression. Who this helps: This helps patients with age-related macular degeneration and their doctors in managing the disease.

Plain English
This study looked at patients with coronary artery disease to identify factors that predict serious heart issues, specifically focusing on the left anterior descending artery (LAD). Researchers found that 32% of the 499 patients had severe narrowing in the LAD, and 12.5% experienced major cardiovascular problems during follow-up. Key risk factors included having a wider left main bifurcation angle, diabetes, and chronic kidney disease, which were tied to higher chances of serious heart events. The CLAP score was created to help doctors assess these risks effectively and improve patient care. Who this helps: This helps patients at risk for heart disease and their doctors in managing treatment strategies.

Plain English
This study focused on a new method for tracking changes in blood flow in the eye's choriocapillaris (a layer of blood vessels) and how these changes relate to eye conditions, particularly in patients with age-related macular degeneration. Researchers looked at data from 90 eyes, revealing that the accuracy of flow measurements varied, but generally stayed within 0.85% to 1.96% for different eye conditions. Importantly, after the resolution of certain eye deposits called drusen, no significant changes in blood flow were found, indicating that this new approach is a reliable way to monitor these changes over time. Who this helps: This helps patients with age-related eye conditions and their doctors by providing a better way to track their eye health.

Plain English
This study looked at how the access point used during a heart procedure (called percutaneous coronary intervention or PCI) affects the risk of kidney injuries in patients who have had a heart attack. The researchers found that using a radial access point (in the wrist) was associated with a lower occurrence of acute kidney injury, with 14.7% of patients experiencing it compared to 21.0% with femoral access (in the groin), although this difference was not statistically strong. This is important because preventing kidney damage can improve recovery and overall health for patients undergoing these procedures. Who this helps: This helps patients with heart attacks by reducing the risk of kidney injury during treatment.

Plain English
This research reviewed advancements in retinal imaging that help doctors better understand eye diseases, particularly age-related macular degeneration (AMD). It highlighted a special imaging technique that shows changes in the eye's blood vessels and discussed how scientists are investigating nerve loss in AMD using detailed imaging methods. These insights can lead to improved diagnoses and treatments for conditions affecting vision. Who this helps: This benefits patients with eye diseases, especially those with age-related conditions.

Plain English
This research looked at how cardiac resynchronization therapy (CRT) can help heart failure patients, particularly those with weak heart function, known as reduced ejection fraction (EF). They found that CRT improves heart performance and reduces hospital visits and overall mortality in these patients. Specifically, it helps the heart pump more effectively and improves patients’ quality of life. Who this helps: This benefits heart failure patients, especially those with reduced ejection fraction.

Plain English
This study looked at a specific feature seen in eye scans of patients with geographic atrophy, a type of vision loss related to age. Researchers analyzed images from 40 people and discovered that each person had an average of about 22 to 25 small, bright spots in the choroid layer of the eye. These spots were found to correlate with the severity of vision loss, which helps in understanding the progression of the disease and could aid in monitoring patients’ condition. Who this helps: This helps patients with geographic atrophy and their doctors by providing better tools for tracking disease progression.

Plain English
This study looked at how carotid endarterectomy (CEA), a surgery to improve blood flow in the neck, affects blood flow in a part of the eye called the choriocapillaris in patients with significant narrowing of the carotid arteries. Researchers found that after surgery, blood flow improved significantly in the eye on the surgical side, with flow deficits decreasing by about 24% and thickness increasing on average by 11%. This is important because it shows that improving blood flow through CEA also helps blood flow in the eyes, which can be essential for maintaining eye health. Who this helps: This benefits patients undergoing CEA, especially older adults with carotid artery narrowing.